Stockreport

2 PARP Concerns On The Move [Seeking Alpha]

TESARO  (TSRO) 
Last tesaro earnings: 11/1 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.tesarobio.com/investor-relations
PDF Summary PARP inhibitor concerns Tesaro and Clovis Oncology have destroyed a lot of shareholder value so far in 2018. However, the stocks have started to rebound [Read more]